PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd (formerly Sun and Shine Worldwide Ltd) reported audited results for FY25 with zero revenue from operations, mirroring a near-dormant business state. The company posted a net loss of Rs. 58.38 lakhs for FY25, wider than the Rs. 19.62 lakhs loss in FY24, with the Q4 FY25 loss alone at Rs. 51.32 lakhs. Cash flow from operations deteriorated sharply to a negative Rs. 190.89 lakhs versus a negative Rs. 4.54 lakhs last year. An exceptional item of Rs. 17.16 lakhs was booked towards an SEBI penalty. The auditor issued an unmodified (clean) opinion on the results.
For shareholders, the picture is concerning: no operating revenue, widening losses, and a steep drop in operating cash flow point to a company struggling for business traction. The shrinking other equity (from Rs. 175.30 to Rs. 116.91 lakhs) signals the capital base is being eroded each year, which could weigh on the stock price and investor confidence.